Located in Delaware,USA, EliveBio Inc. was founded by a team of successful entrepreneurs with decades of experience in synthetic biology and bio-pharmaceuticals. Medicine has evolved over the last few decades from considering all microorganisms to be potential health threats, to identifying their role in maintaining physiologic functions of the human host. Using our revolutionary synthetic biology platform, a “safe” bacteria can be programmed to enter a target organ, “sense” the disease status, produce a therapeutic drug molecule, and self-destruct upon completion. This in situ drug production greatly reduces the off-target effects, and has a wide range of applications that can be utilized to help improve the patient’s quality of life.